BJS Academy
>
Randomized clinical ...
>
Event free survival ...
Normal View
Dyslexic View
Facebook
Twitter
Linkedin
Email
Copy Link
Copy embeded link
Event-free survival with pembrolizumab in early triple-negative breast cancer.
1 March 2022
Randomized clinical trials
Breast
Home
View
Normal view
Dyslexic view
Info
Share
Facebook
Twitter
Linkedin
Email
Copy Link
Copy embeded link
Copied!